Next, AK5 is a member of adenylate kinase family that was previous shown to be highly expressed in leukemia stem cells (LSCs) compared to human hematopoietic stem cells (HSCs), indicating potential therapeutic targets for quiescent and chemotherapy-resistant human LSCs [54]. The gene discussed is AK5; the disease is leukemia.